Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Stage Researcher (R1) Positions PhD Positions Country Sweden Application Deadline 24 Oct 2025 - 00:00 (Europe/Stockholm) Type of Contract Temporary Job Status Full-time Is the job funded through the EU
-
Researcher (R1) Positions PhD Positions Country Sweden Application Deadline 24 Oct 2025 - 00:00 (Europe/Stockholm) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research
-
Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country Sweden Application Deadline 24 Oct 2025 - 00:00 (Europe/Stockholm) Type of Contract Temporary Job Status Full-time Is the job
-
applicants must hold a PhD in psychology or a closely related discipline. The degree must be completed before the start of employment. We are looking for a researcher with a strong interest in attitudes
-
to the application deadline. In special circumstances, the doctoral degree may have been obtained earlier. Additional requirements: PhD in the life sciences Very good oral and written proficiency in English
-
three years prior to the application deadline. In special circumstances, the doctoral degree may have been obtained earlier. Additional requirements: PhD in the life sciences Very good oral and written
-
well as clinical service or service/assignment relevant to the subject area. Assessment criteria A PhD in molecular biology, physiology, bioinformatics, mathematics, or other quantitative biosciences. Experience in
-
note in particular that the following documents must accompany the application: PhD degree (in Swedish or English) Certificate medical degree Certificate specialist competence in Rehabilitation Medicine
-
positions with a specialisation in science, Swedish, or technology. Job Duties Doctoral education involves four years of full-time study leading to a PhD degree. Information about the programme is available
-
in modulating bile duct inflammation and fibrosis using translational research models of PSC. This PhD project will employ a combination of in vitro (immortalized and primary cholangiocytes), ex vivo